199 related articles for article (PubMed ID: 30173899)
1. HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy.
Wang HY; Cui Z; Xie LJ; Zhang LJ; Pei ZY; Chen FJ; Qu Z; Huang J; Zhang YM; Wang X; Wang F; Meng LQ; Cheng XY; Liu G; Zhou XJ; Zhang H; Debiec H; Ronco P; Zhao MH
Kidney Int; 2018 Nov; 94(5):974-982. PubMed ID: 30173899
[TBL] [Abstract][Full Text] [Related]
2. HLA Alleles and Prognosis of PLA2R-Related Membranous Nephropathy.
Le WB; Shi JS; Fan Y; Gong SW
Clin J Am Soc Nephrol; 2021 Aug; 16(8):1221-1227. PubMed ID: 34083219
[TBL] [Abstract][Full Text] [Related]
3. MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.
Cui Z; Xie LJ; Chen FJ; Pei ZY; Zhang LJ; Qu Z; Huang J; Gu QH; Zhang YM; Wang X; Wang F; Meng LQ; Liu G; Zhou XJ; Zhu L; Lv JC; Liu F; Zhang H; Liao YH; Lai LH; Ronco P; Zhao MH
J Am Soc Nephrol; 2017 May; 28(5):1651-1664. PubMed ID: 27852637
[TBL] [Abstract][Full Text] [Related]
4. HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy.
Le WB; Shi JS; Zhang T; Liu L; Qin HZ; Liang S; Zhang YW; Zheng CX; Jiang S; Qin WS; Zhang HT; Liu ZH
J Am Soc Nephrol; 2017 May; 28(5):1642-1650. PubMed ID: 28028136
[TBL] [Abstract][Full Text] [Related]
5. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
[TBL] [Abstract][Full Text] [Related]
6. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE
Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522
[TBL] [Abstract][Full Text] [Related]
7. Identification of a two-SNP PLA2R1 Haplotype and HLA-DRB1 Alleles as Primary Risk Associations in Idiopathic Membranous Nephropathy.
Latt KZ; Honda K; Thiri M; Hitomi Y; Omae Y; Sawai H; Kawai Y; Teraguchi S; Ueno K; Nagasaki M; Mabuchi A; Kaga H; Komatsuda A; Tokunaga K; Noiri E
Sci Rep; 2018 Oct; 8(1):15576. PubMed ID: 30349113
[TBL] [Abstract][Full Text] [Related]
8. PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians.
Ramachandran R; Kumar V; Kumar A; Yadav AK; Nada R; Kumar H; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
Nephrol Dial Transplant; 2016 Sep; 31(9):1486-93. PubMed ID: 26673907
[TBL] [Abstract][Full Text] [Related]
9. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy.
Lv J; Hou W; Zhou X; Liu G; Zhou F; Zhao N; Hou P; Zhao M; Zhang H
J Am Soc Nephrol; 2013 Jul; 24(8):1323-9. PubMed ID: 23813219
[TBL] [Abstract][Full Text] [Related]
10. Combined Serologic and Genetic Risk Score and Prognostication of Phospholipase A2 receptor-Associated Membranous Nephropathy.
Hu X; Xu J; Wang W; Liu L; Jing Y; Gao C; Yu X; Li Y; Lin L; Tong J; Weng Q; Pan X; Zhang W; Ren H; Li G; Kiryluk K; Chen N; Xie J
Clin J Am Soc Nephrol; 2024 May; 19(5):573-582. PubMed ID: 38423528
[TBL] [Abstract][Full Text] [Related]
11. Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy.
Liu X; Xu W; Yu C; Wang M; Liu R; Xie R
Bioengineered; 2021 Dec; 12(1):8833-8844. PubMed ID: 34607530
[TBL] [Abstract][Full Text] [Related]
12. Identical twins with idiopathic membranous nephropathy.
Tao T; Wang J; Lei S; Hu Z
J Nephrol; 2021 Apr; 34(2):597-601. PubMed ID: 32524521
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
14. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
[TBL] [Abstract][Full Text] [Related]
15. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
[TBL] [Abstract][Full Text] [Related]
16. Deep pockets are not necessarily a good thing in membranous nephropathy: evidence for a modifier allele.
Beck LH; Salant DJ
Kidney Int; 2018 Nov; 94(5):855-857. PubMed ID: 30348302
[TBL] [Abstract][Full Text] [Related]
17. The pathogenesis of membranous nephropathy: evolution and revolution.
Glassock RJ
Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552
[TBL] [Abstract][Full Text] [Related]
18. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study.
Yin P; Wang J; Liang W; Zhan L; Liu Y; Lin J; Chen X; He Y; Jian H; Xie Z; Tan X; Ye Q; Huang F
Ren Fail; 2020 Nov; 42(1):675-683. PubMed ID: 32674643
[TBL] [Abstract][Full Text] [Related]
20. Primary membranous nephropathy in two siblings with one combined with anti-glomerular basement membrane disease: a case report.
Cheng YJ; Jia XY; Cao HR; Zhao XY; Zhou XJ; Yu XJ; Xu R; Zhou FD; Wang SX; Cui Z; Zhao MH
BMC Nephrol; 2023 Jun; 24(1):183. PubMed ID: 37349681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
